Suchergebnisse - "Huettner, Isabella"

PubPharm (16)

1

ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants

enthalten in: bioRxiv.org | 2023

von Seow, J. | Graham, C. | Hallett, S. | +13

2

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

enthalten in: PLoS pathogens | 2022

von Graham, C. | Lechmere, T. | Rehman, A. | +13

3

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination

enthalten in: Cell reports | 2022

von Seow, J. | Khan, H. | Rosa, A. | +10

4

ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19

enthalten in: International journal of obesity (2005) | 2022

von El-Sayed Moustafa, J. | Jackson, A. | Brotman, S. | +33

UpdateOf: medRxiv. 2020 Aug 14;:. - PMID 32817962

5

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

enthalten in: bioRxiv.org | 2022

von Graham, C. | Lechmere, T. | Rehman, A. | +13

6

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

enthalten in: eLife | 2022

von Fielding, C. | Sabberwal, P. | Williamson, J. | +18

7

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

enthalten in: Cell reports | 2022

von Seow, J. | Graham, C. | Hallett, S. | +15

8

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

enthalten in: Cell reports | 2022

von Huettner, I. | Krumm, S. | Serna, S. | +28

CommentIn: Trends Parasitol. 2022 Jul;38(7):498-500. - PMID 35501266

9

Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort

enthalten in: AIDS (London, England) | 2021

von Granger, L. | Huettner, I. | Debeljak, F. | +14

10

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

enthalten in: Nature microbiology | 2021

von Dupont, L. | Snell, L. | Graham, C. | +29

UpdateOf: medRxiv. 2021 Jun 08;:. - PMID 34127977